ZIVO News and Press, Zivo Bioscience Inc. From 05/30/23

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced it has received an updated dossier from an indepe...

2023-05-24 12:02:25 ET In its preliminary annual 2023 Russell indexes reconstitution, the following consumer companies will be added to and deleted from the Russell microcap index: Notable additions: Stitch Fix ( SFIX ), Genius Brands ( GNUS ), 2U ( TWOU ), Big Lots ( ...

2023-04-05 16:35:15 ET Zivo Bioscience ( NASDAQ: ZIVO ) on Wednesday said it got a $1 million unsecured six-month loan from its CEO John Payne. The loan carries 10% simple interest and may be prepaid without penalty. The loan is extendable for an additional ...

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced a $1 million unsecured six-month loan from its C...

2023-03-23 10:06:23 ET Gainers: ZyVersa Therapeutics ( ZVSA ) +33% . Aziyo Biologics ( AZYO ) +29% . Generation Bio ( GBIO ) +20% . HTG Molecular Diagnostics ( HTGM ) +16% . scPharmaceuticals ( SCPH ) +15% . Losers:...

Due to an unexpectedly high mortality rate among tested chickens, ZIVO to conduct a new study with results expected by mid-year Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal ...

ZIVOLife to be Granted Exclusive Worldwide Limited License to ZIVO Bioscience Intellectual Property for the Production and Supply of Whole Biomass Algal Products Conference call to be held in early November Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company&...

Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today issued the following letter to shareholders from its Chairman, President and ...

Regulatory Clarity Enables ZIVO to Focus and Optimize Development Strategy ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived...

ZIVO Bioscience (NASDAQ:ZIVO) has joined the Russell Microcap® Index, effective from June 27, 2022. “Our inclusion reflects continued interest in our stock along with long- and near-term growth expectations as we evolve and execute on our business strategy.” stated John Pay...